A Long-Term Follow-Up Study of Patients with Hematologic Malignancies Who Were Previously Enrolled in Amgen-Sponsored Clinical Trials Using Recombinant Human Keratinocyte
|Effective start/end date||7/19/01 → 12/31/13|
- AMGEN INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.